Siglec-2/CD22 Antibody (RFB4) [PE]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-49890PE
Key Product Details
Species Reactivity
Validated:
Human, Canine
Cited:
Canine
Applications
Validated:
Flow Cytometry, Immunocytochemistry/ Immunofluorescence, Immunofluorescence
Cited:
FLOW
Label
PE (Excitation = 488 nm, Emission = 575 nm)
Antibody Source
Monoclonal Mouse IgG1 Clone # RFB4
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
135 kDa type I integral membrane protein
Reactivity Notes
Use in Canine reported in scientific literature (PMID:31826004).
Specificity
This antibody recognizes surface Siglec-2/CD22 expressed by mature peripheral B-cells and cytoplasmatic Siglec-2/CD22 expressed by precursor B-cells. The sensitivity is determined by staining well-defined blood samples from representative donors with serial-fold mAb dilutions to obtain a titration curve that allows relating the mAb concentration to the percentage of stained cells and geometric MFI (mean fluorescence intensity).For this purpose, a mAb-concentration range is selected to include both the saturation point (i.e. the mAb dilution expected to bind all epitopes on the target cell) and the detection threshold (i.e. the mAb dilution expected to represent the least amount of mAb needed to detect an identical percentage of cells). In practice, 50 ul of leukocytes containing 10^7 cells/ml are stained with 20 ul mAb of various dilutions to obtain a titration curve and to identify the saturation point and detection threshold. The final concentration of the product is then adjusted to be at least 3-fold above the detection threshold. In addition and to control lot-to-lot variation, the given lot is compared and adjusted to fluorescence standards with defined intensity.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1
Description
For stability reasons this monoclonal antibody solution contains sodium azide. These reagents should be stored at 2-8C (DO NOT FREEZE!) and protected from prolonged exposure to light. If a slight precipitation occurs upon storage, this should be removed by centrifugation. It will not affect the performance or the concentration of the product. Stability of the reagent: Please refer to the expiry date printed onto the vial. The use of the reagent after the expiration date is not recommended.
Scientific Data Images for Siglec-2/CD22 Antibody (RFB4) [PE]
Flow Cytometry: Siglec-2/CD22 Antibody (RFB4) [PE] [NBP2-49890PE] - Flow cytometric analysis of a normal blood sample after immunostaining with Siglec-2/CD22 Antibody (RFB4) [PE].
Flow Cytometry: Siglec-2/CD22 Antibody (RFB4) [PE] [NBP2-49890PE] - Flow cytometric analysis of a normal blood sample after immunostaining with Siglec-2/CD22 Antibody (RFB4) [PE].
Applications for Siglec-2/CD22 Antibody (RFB4) [PE]
Application
Recommended Usage
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Immunocytochemistry/ Immunofluorescence
Optimal dilutions of this antibody should be experimentally determined.
Immunofluorescence
Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified
Formulation
PBS (pH 7.2) and 1.0% (w/v) BSA
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Siglec-2/CD22
Long Name
Sialic Acid Binding Ig-like Lectin 2
Alternate Names
BL-CAM, CD22, Siglec2
Gene Symbol
CD22
Additional Siglec-2/CD22 Products
Product Documents for Siglec-2/CD22 Antibody (RFB4) [PE]
Product Specific Notices for Siglec-2/CD22 Antibody (RFB4) [PE]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...